Ligand validation:3B3Q

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3B3Q designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3B3Q_NAG_A_636	1%	45%	0.471	0.617	0.72	1.38	-	3	0	0	100%	1
3BIX_NAG_B_2	94%	69%	0.064	0.963	0.65	0.53	-	-	2	0	100%	1
3VKF_NAG_A_2001	56%	69%	0.088	0.858	0.48	0.7	-	-	0	0	100%	1
5OJK_NAG_B_701	41%	90%	0.204	0.92	0.26	0.33	-	-	0	0	100%	1
5OJ6_NAG_B_1011	31%	74%	0.206	0.875	0.29	0.7	-	1	0	0	100%	1
3BIW_NAG_A_702	20%	51%	0.097	0.698	1.07	0.83	1	1	2	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.